Diagnosis of regional cerebral blood flow abnormalities using spect: Agreement between individualized statistical parametric maps and visual inspection by nuclear medicine physicians with different levels of expertise in nuclear neurology

Clinics

Volumn 64, Issue 12, 2009, Pages 1145-1153

  da Rocha, Euclides Timóteo ^a,b   Buchpiguel, Carlos Alberto ^c,d   Nitrini, Ricardo ^d   Tazima, Sergio ^e   Peres, Stela Verzinhase ^f   Busatto Filho, Geraldo ^d,g  

^a Fundacao Pio XII   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c Hospital do Coracao   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e HOSPITAL ALEMÃO OSWALDO CRUZ   (Brazil)

^f Hospital de Câncer   (Brazil)

^g Institute of Psychiatry   (Brazil)

Author keywords

Brain SPECT; Cerebral blood flow; Dementia; ECD; Statistical parametric mapping

Indexed keywords

ADULT; AGED; ARTICLE; AUTOMATED PATTERN RECOGNITION; BRAIN; BRAIN CIRCULATION; BRAIN DISEASE; BRAIN MAPPING; CASE CONTROL STUDY; EDUCATIONAL STATUS; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NUCLEAR MEDICINE; OBSERVER VARIATION; PATHOPHYSIOLOGY; REPRODUCIBILITY; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STANDARD; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; BRAIN DISEASES; BRAIN MAPPING; CASE-CONTROL STUDIES; CEREBROVASCULAR CIRCULATION; EDUCATIONAL STATUS; FEMALE; HUMANS; MALE; MIDDLE AGED; NUCLEAR MEDICINE; OBSERVER VARIATION; PATTERN RECOGNITION, AUTOMATED; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 75649102420     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322009001200003     Document Type: Article

References (32)

1. Grunwald F, Menzel C, Pavics L, Bauer J, Hufnagel A, Reichmann K, et al. Ictal and inter-ictal brain SPECT using tecnhnetium-99mECD. J. Nucl. Med. 1994;35:1896-901.
2. Bonte FJ, Tintner R, Weiner MF, Bigio EH, White CL 3rd. Brain-blood flow in the dementias: SPECT with hystopathologic correlation. Radiology. 1993;186:361-5.
3. Bavetta S, Nimmon CC, White J, McCabe J, Huneidi AH, Bomanji J, et al. A prospective study comparing SPECT with MRI and CT as prognostic indicators following severe closed head injury. Nucl. Med. Commun. 1994;15:961-8.
4. Kim JS, Monn DH, Kim GE, Cho PC, Kim JS, Ryu JS, et al. Acetazolamide stress brain-perfusion SPECT predicts the need for carotid shunting during carotid endarterectomy. J. Nucl. Med. 2000;4:1836-41.
5. Clauss JJ, van Harskamp K, Breteler MM, Krenning E P, Van Der Cammen, TJ Hofman A, et al. Assessment of cerebral perfusion with single-photon emission tomography in normal subjects and in patients with Alzheimer's disease effects of region of interest selection. Eur. J. Nucl. Med. 1994;21:1044-51.
6. Liu HG, Mountz JM, Inampudi C, San Pedro EC, Deutsch G. A semiquantitative cortical circumferential normalization method for clinical evaluation of rCBF brain SPECT. Clin Nuc Med. 1997;22:596-604.
7. Woods RP. Modeling for intergroup comparisons of imaging data. Neuroimage. 1996;4:S84-S94.
8. Van Horn JD, Ellmore TM, Esposito G, Berman KF. Mapping voxel-based statistical power on parametric images. Neuroimage. 1998;7:97-107.
9. Friston KJ, Frith CD, Liddle PF, Frackowiak RS. Comparing functional (PET) images: the assessment of significant change. J. Cereb. Blood Flow Metab. 1991;11:690-9.
10. Chaim TM, Duran FL, Uchida RR, Périco CA, de Castro CC, Busatto GF. Volumetric reduction of the corpus callosum in Alzheimer's disease in vivo as assessed with voxel-based morphometry. Psychiatry Res. 2007; 15; 154:59-68.
11. Chou YY, Leporé N, Avedissian C, Madsen SK, Parikshak N, Hua X, et al. Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alheimer's disease, mild cognitive impairment and elderly controls. Neuroimage. 2009;46:394-410.
12. Stein DJ, Arya M, Pietrini P, Rapoport JL, Swedo SE. Neurocircuitry of disgust and anxiety in obsessive-compulsive disorder:a positron emission tomography. Metab Brain Dis. 2006;21:267-77.
13. Stamatakis EA, Glabus MF, Wyper DJ, Barnes A, Wilson JT. Validation of statistical parametric mapping in assessing cerebral lesions: a simulation study. Neuroimage. 1999;10:397-07.
14. Busatto GF, Zamignani DR, Buchpiguel CA, Garrido GE, Glabus MF, Rocha ET, et al. A voxel-based investigation of regional cerebral blood flow abnormalities in obsessive-compulsive disorder using single photon emission computed tomography (SPECT). Psychiatry Res. 2000;99:15-27.
15. Ebmeier KP, Glabus MF, Prentice N, Ryman A, Goodwin GM. A voxel-based analysis of cerebral perfusion in dementia and depression of old age. Neuroimage. 1998;7:199-08.
16. Signorini M, Paulesu E, Friston K, Perani D, Colleluori A, Lucignani G, et al. Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and non-quantitative 18F-FDG PET: a clinical validation of statistical parametric mapping. Neuroimage. 1999;9:63-80.
17. Lee JD, Kim HJ, Lee BI, Kim OJ, Jeon TJ, Kim MJ. Evaluation of ictal brain SPECT using statistical parametric mapping in temporal lobe epilepsy. Eur. J. Nucl. Med. 2000;27:1658-65.
18. Chang DJ, Zubal IG, Gottschalk C, Necochea A, Stokking R, Studholme C, et al. Comparison of statistical parametric mapping and SPECT difference imaging in patients with temporal lobe epilepsy. Epilepsia. 2002;43:68-4.
19. Ohta Y, Nariai T, Ishii K, Ishiwata K, Mishina M, Senda M, et al. Voxel-and ROI-based statistical analyses of PET parameters for guidance in the surgical treatment of intractable mesial temporal lobe epilepsy. Ann Nuc Med. 2008;22:495-503.
20. Stamatakis EA, Wilson JT, Hadley DM, Wyper DJ.SPECT imaging in head injury interpreted with statistical parametric mapping. J. Nucl. Med. 2002;43:476-83.
21. Barnes A, Lusman D, Patterson J, Brown D, Wyper D. The use of statistical parametric mapping (SPM96) as a decision aid in the differential diagnosis of dementia using 99mTc-HMPAO SPECT. Behav. Neurol. 2000;12:77-86.
22. Kemp PM, Hoffmann SA, Holmes C, Bolt L, Ward T, Holmes RB, et al. The contribution of statistical parametric mapping in the assessment of precuneal and medial temporal lobe perfusion by 99mTc-HMPAO SPECT in mild Alzheimer's and Lewy body dementia. Nucl Med Commun. 2005;26:1099-106.
23. First MB, Spitzer RL, Willians JBW, Gibbons M. Structures Clinical Interview for DSM-IV-Patients Editiin. SCIDP. American Psychiatric Press, Washington, DC. 1995.
24. Talairach J, Tournoux P. Coplanar stereotaxic atlas of the human brain. New Y, NY: Thieme Medical; 1998.
25. Friston KJ, Holmes A, Poline JB, Price CJ, Frith CD. Detecting activations in PET and FMRI: levels of inference and power. Neuroimage. 1996;4:223-35.
26. Kang X, Berman DS, Van Train KF, Amanullah AM, Areeda J, Friedman JD, Clinical validation of automatic quantitative defect size in rest technetium-99m-sestamibi myocardial perfusion SPECT. J Nuc Med. 1997;38:1441-6.
27. Ishii K, Willoch F, Minoshima S, Drzezga A, Ficaro EP, Cross DJ, et al. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains. J. Nucl. Med. 2001;42:548-57.
28. Hosaka K, Ishii K, Sakamoto S, Sadato N, Fukuda H, Kato T, et al. Validation of anatomical standardization of FDG PET images of normal brain: comparison of SPM and NEUROSTAT. Eur J Nucl Med Mol Imaging. 2005;32:92-7.
29. Thompson PM, Schwartz C, Lin RT, Khan AA, Toga AW. Three-dimensional statistical analysis of sulcal variability in the human brain. J. Neurosci. 1996;16:4261-74.
30. Kalatzis I, Pappas D, Piliouras N, Cayouras D. Support vector machines based analysis of brain SPECT images for determining cerebral abnormalities in asymptomatic diabetic patients. Med Inform Internet Med. 2003;28:221-30.
31. Glenn Fung, Jonathan Stoeckel. SVM feature selection for classification of SPECT images of Alzheimer's disease using spatial information. Knowledge and Information Systems. Springer. 2007;2:243-58.
32. Dougall N, Nobili F, Ebmeier KP. Predicting the accuracy of a diagnosis of Alzheimer's disease with 99mTc HMPAO single photon emission computed tomography. Psychiatry Res. 2004;131:157-68.